QuidelOrtho Corp

QDEL Nasdaq SEC CIK 1906324
Follow QuidelOrtho Weekly email: filings, results

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income6 fiscal years
  • Revenue
  • Net income
−$4B−$2B$0$2B$4BFY21FY22FY23FY24FY25FY26
Show the numbers
YearRevenueNet income
FY26$2.7B−$1.1B
FY25$2.8B−$2.1B
FY24$3B−$10.1M
FY23$3.3B$548.7M
FY22$1.7B$704.2M
FY21$1.7B$810.3M
MarginsShare of revenue
  • Operating margin
  • Net margin
−100%−50%0%50%100%FY21FY22FY23FY24FY25FY26
Show the numbers
YearOperating marginNet margin
FY26−33.7%−41.5%
FY25−70.5%−73.7%
FY244.6%−0.3%
FY2325.8%16.8%
FY2253.3%41.5%
FY2163.8%48.8%
Free cash flowOperating cash flow minus capital expenditure
−$250M$0$250M$500M$750MFY21FY22FY23FY24FY25FY26
Show the numbers
YearFree cash flow
FY26−$83M
FY25−$112.1M
FY24$70.9M
FY23$744.4M
FY22$513.1M
FY21$564.8M
Returned to shareholdersDividends paid and shares bought back
$0$50M$100M$150MFY21FY22FY23FY24FY25FY26
Show the numbers
YearBuybacks
FY26$0
FY25$0
FY24$7.2M
FY23$74.3M
FY22$103.5M
FY21$43.7M
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • QuidelOrtho
  • Healthcare median
−100%−50%0%50%FY21FY22FY23FY24FY25FY26
Show the numbers
YearQuidelOrthoHealthcare median
FY26−41.5%−11.1%
FY25−73.7%−30.6%
FY24−0.3%−47%
FY2316.8%−58%
FY2241.5%−80.4%
FY2148.8%−71.9%